Abstract
BackgroundUnderstanding the interaction between Aedes vectors and dengue viruses (DENV) has significant implications in determining the transmission dynamics of dengue. The absence of an animal model and ethical concerns regarding direct feeding of mosquitoes on patients has resulted in most infection studies using blood meals spiked with laboratory-cultured DENV. Data obtained from such studies may not reflect the natural human-mosquito transmission scenario. This study explored the potential of using membrane feeding of dengue patient’s blood as a substitute for direct skin feeding.MethodsFour to six-day old female Ae. aegypti were provided the opportunity to feed via direct exposure to a patient’s forearm for 15 min or via exposure to EDTA-treated blood from the same patient through an artificial membrane for 30 min. Mosquitoes from both feeding methods were incubated inside environmental chambers. Mosquitoes were sampled at day 13 post-feeding. Midgut and salivary glands of each mosquito were dissected to determine DENV infection by RT-qPCR and viral titration, respectively.ResultsFeeding rates: Direct skin feeding assay (DSFA) consistently showed higher mosquito feeding rates (93.3–100 %) when compared with the membrane feeding assay (MFA) (48–98.2 %). Midgut infection: Pair-wise comparison between methods showed no significant difference in midgut infection rates between mosquitoes exposed via each method and a strong correlation was observed in midgut infection rates for both feeding methods (r = 0.89, P < 0.0001). Overall midgut viral titers (n = 20) obtained by both methods were comparable (P ≥ 0.06). Salivary gland infection: Pair-wise comparison between both methods revealed no significant difference in salivary gland infection rate. Strong correlation in salivary gland infection was observed between DSFA and MFA (r = 0.81, P < 0.0001). In general, mosquitoes fed directly on dengue patients and those on patients’ blood (n = 11) had comparable virus titer (P ≥ 0.09).ConclusionDENV midgut and salivary gland infection rates showed good concordance between DSFA and MFA blood meal exposure methods. Freshly-obtained venous blood in EDTA from dengue patients for MFA can be used as a substitute to DSFA, especially in circumstances where bioethics approval or patient recruitment is difficult to obtain for vector competence studies. Nevertheless, mosquito numbers will need to be increased to compensate for lower feeding rate in MFA.Electronic supplementary materialThe online version of this article (doi:10.1186/s13071-016-1469-6) contains supplementary material, which is available to authorized users.
Highlights
Understanding the interaction between Aedes vectors and dengue viruses (DENV) has significant implications in determining the transmission dynamics of dengue
The largest and most comprehensive studies involving human volunteers were conducted by Nguyen et al [8] in Vietnam which revealed that the majority of symptomatic, ambulatory dengue patients were important sources of infection for vectors and that DENV plasma viremia levels served as an important marker of the duration of human infectiousness to Ae. aegypti
Feeding rates Overall, Direct skin feeding assay (DSFA) consistently resulted in higher mosquito feeding rates when compared to membrane feeding (Table 1)
Summary
Understanding the interaction between Aedes vectors and dengue viruses (DENV) has significant implications in determining the transmission dynamics of dengue. The absence of an animal model and ethical concerns regarding direct feeding of mosquitoes on patients has resulted in most infection studies using blood meals spiked with laboratory-cultured DENV. Data obtained from such studies may not reflect the natural human-mosquito transmission scenario. Once dengue viruses (DENV) have reached the salivary glands, transmission of virus to susceptible hosts may occur during subsequent blood meals. This process is important in shaping the epidemiology of dengue and is greatly affected by a myriad of viral, mosquito, host and environmental factors. The study defined serotype-specific viremia thresholds which must be reached by vaccines or drugs to prevent DENV transmission
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.